Barclays
MEDP icon

Barclays’s Medpace MEDP Stock Holding History

Barclays’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-30,000
Closed -$6.53M – 5364
2021
Q4 		$6.53M Sell
30,000
-21,400
-42% -$4.48M ﹤0.01% 1525
2021
Q3 		$9.73M Buy
+51,400
New +$9.37M ﹤0.01% 1213

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Barclays's MEDP Position: Q2 2026 in Review

Barclays reduced its Medpace (MEDP) stake by 59% in Q2 2026, selling an estimated $17M and leaving 25,775 shares worth $13.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1326.

Barclays first reported a position in MEDP in Q3 2016 and has held it in 40 quarters since. The position peaked at $30.1M in Q1 2026. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Barclays held 25,775 shares of Medpace worth $13.7M as of Q2 2026.
  • Barclays sold 36,932 Medpace shares in Q2 2026, an estimated $17M.
  • Medpace made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1326 holding.
  • Barclays first reported a position in Medpace in Q3 2016 and has held it in 40 quarters since.
  • Barclays's Medpace position peaked at $30.1M in Q1 2026.
  • 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.